Prevention better than cure? Enter predictive genomics

Harnessing the genome to innovate prevention

Wednesday, 28 September 2022 | 11:00-12:30 | Conference Centre

Organised by Thermo Fisher Scientific

As the COVID-19 dust slowly settles, we are reminded of public health enemy number one: the rising burden of non-communicable diseases (NCDs). Existing efforts to prevent NCDs are clearly not sufficient to weather the socio-economic storm caused by ageing populations and lowering fertility rate.  Societies shall face economic and resource challenges in the prevention of inequitable healthcare. 

The most effective solution to ensure sustainable and fair healthcare systems is to shift their design to keeping people healthier for longer, and to prevent the preventable. Enter predictive genomics.  

What is predictive genomics, and can it innovate prevention? What are the risks? Four experts will debate these questions and more in a fast-paced debate where the audience participants will have their say on the future of predictive genomics. 

Session recording


  • Mark Smedley, Senior Vice President and President, Genetic Sciences Group, Thermo Fisher Scientific
  • Mahsa Shabani, Assistant Professor, Ghent University
  • Tuula Helander, Deputy Director General, Ministry of Social Affairs and Health, Finland
  • Andrea Ganna, FIMM-EMBL Group Leader, Institute for Molecular Medicine Finland, University of Helsinki


EHFG News & Updates

EHFG Headquarters

EHFG Vienna Office